These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2974690)

  • 1. Changes in immune function in relapsing multiple sclerosis correlate with disease activity as assessed by magnetic resonance imaging.
    Oger J; O'Gorman M; Willoughby E; Li D; Paty DW
    Ann N Y Acad Sci; 1988; 540():597-601. PubMed ID: 2974690
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI.
    Oger J; Kastrukoff LF; Li DK; Paty DW
    Neurology; 1988 Nov; 38(11):1739-44. PubMed ID: 3185908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T-lymphocytes with a receptor for the immunoglobulin Fc fragment in the blood of multiple sclerosis patients].
    Czernicki J; Rzetelski B
    Neurol Neurochir Pol; 1981; 15(5-6):559-64. PubMed ID: 6210849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
    Oger JJ; Antel JP; Kuo HH; Arnason BG
    Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.
    Bania MB; Antel JP; Reder AT; Nicholas MK; Arnason BG
    J Clin Invest; 1986 Aug; 78(2):582-6. PubMed ID: 2942563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cell activity in multiple sclerosis.
    Wallen WC; Houff SA; Iivanainen M; Calabrese VP; DeVries GH
    Neurology; 1981 Jun; 31(6):668-74. PubMed ID: 6454082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed regulatory T cell homeostasis in multiple sclerosis.
    Venken K; Hellings N; Liblau R; Stinissen P
    Trends Mol Med; 2010 Feb; 16(2):58-68. PubMed ID: 20159585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function.
    Herscowitz HB; Sakane T; Steinberg AD; Green I
    J Immunol; 1980 Mar; 124(3):1403-10. PubMed ID: 6444652
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlating immunological and magnetic resonance imaging markers of disease activity in multiple sclerosis.
    Giovannoni G; Kieseier B; Hartung HP
    J Neurol Neurosurg Psychiatry; 1998 May; 64 Suppl 1():S31-6. PubMed ID: 9647282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    Ann Neurol; 1992 Jan; 31(1):103-6. PubMed ID: 1371908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation in multiple sclerosis.
    Arnason BG; Antel JP; Reder AT
    Ann N Y Acad Sci; 1984; 436():133-9. PubMed ID: 6241817
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoadsorption patients with multiple sclerosis: an open-label pilot study.
    Moldenhauer A; Haas J; Wäscher C; Derfuss T; Hoffmann KT; Kiesewetter H; Salama A
    Eur J Clin Invest; 2005 Aug; 35(8):523-30. PubMed ID: 16101673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
    Zweiman B; Lisak RP
    Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue.
    Sobel RA; Hafler DA; Castro EE; Morimoto C; Weiner HL
    Ann N Y Acad Sci; 1988; 540():306-8. PubMed ID: 2905121
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging in multiple sclerosis: analysis of correlations to peripheral blood and spinal fluid abnormalities.
    Farlow MR; Edwards MK; Kolar OJ; Stevens JC; Yu PL
    Neurology; 1987 Sep; 37(9):1527-30. PubMed ID: 2957612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
    Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
    N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis.
    Richman DP; Dropcho EJ; Antel JP; Arnason BG
    Trans Am Neurol Assoc; 1978; 103():191-3. PubMed ID: 316215
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of polymorphonuclear leukocyte (PMNL) factors on T suppressor cell function in in vitro studies in healthy persons and some autoimmune disorders.
    Czernicki J; Tchórzewski H; Lewicki R; Orzel H
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):355-60. PubMed ID: 6457583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.
    Crockard AD; McNeill TA; McKirgan J; Hawkins SA
    J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):139-41. PubMed ID: 2965217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.